Unlike other injectables and chemical peels, dermal fillers don’t present any adverse reactions to direct sun exposure. With dermal filler treatments, patients don’t need to worry about over-compensating on their after-care. This is because the injectables are not susceptible to sun sensitivity which makes dermal fillers the perfect summer-time treatment.
Dermal fillers are intended to help restore facial volume and reduce the appearance of fine lines and wrinkles. Smoothing depressions in the skin, dermal fillers also restore healthy-looking plumpness and are a popular alternative for facial augmentation. One treatment that patients are particularly fawning over this summer is tear trough filler – an efficacious treatment for bags, volume loss and dark circles under the eyes. Tear trough filler is intended to help create a fresher and more youthful appearance for patients who want to embrace the no-makeup look during the summer season. By injecting dermal fillers into the under-eye area, the replacement of volume loss helps to improve the tired-looking appearance many of us face as we age, meaning a makeup-free summer without the need for concealer.
Formulated with Hyaluronic Acid (HA), dermal fillers provide instant results when injected to help refresh and add plumpness to a patient’s appearance with minimal to no downtime. The Nation’s Favourite Dermal Filler, REVOLAX, is the perfect go-to for clients’ summer ‘glow-ups’. With three expert dermal fillers in the range, REVOLAX enhances in the most natural-looking way, boasting a low percentage of product migration. This means that once injected, the product is more likely to stay close to the injection site. As REVOLAX is highly crosslinked, the skin takes longer to break down the Hyaluronic Acid (HA) meaning REVOLAX dermal fillers are more long-lasting than their rival competitors. Patients can rest assured that their filler treatments will last throughout the season.
For more on the REVOLAX range, see our blog here or shop directly from the UK rightsholders at Fox Pharma.